CNM-Au8 Fails at Key RESCUE-ALS Trial Goals, But Trends ‘Encouraging’
CNM-Au8, an investigational disease-modifying therapy for people with early amyotrophic lateral sclerosis (ALS), failed to prevent motor neurons…
Articles by Steve Bryson, PhD
Amylyx Seeks U.S. Approval of AMX0035 With FDA Filing
Amylyx Pharmaceuticals is seeking approval in the U.S. for AMX0035, its investigational therapy for slowing functional decline in people…
Cell Atlas of Motor Cortex, Brain Region That Controls Movement, Created
A detailed atlas of the various types of cells that populate the motor cortex, the brain region that controls voluntary…
SBT-272 Supports Health of Mitochondria in ALS Mouse Model
An investigational treatment for amyotrophic lateral sclerosis (ALS), SBT-272 was found to sustainably reach different brain regions, and to protect…
Loss of C9orf72, ALS-linked Gene, Affects Motor Skills in Early StudyÂ
Diminished activity in the C9orf72 gene that is linked with amyotrophic lateral sclerosis (ALS) affected the neuromuscular junction — where nerve…
Risk of Diseases Like ALS Almost 4 Times Higher in Professional Soccer
Men who played professional soccer were nearly four times more likely to develop a neurodegenerative disorder, including a motor neuron…
Motor Neurons From Patients ‘Powerful’ Way of Spotting Therapies
Using motor neurons derived from people with amyotrophic lateral sclerosis (ALS) is a promising approach to screen for molecules…
Frequent, Intense Exercise May Promote ALS in Those With Risk Genes
Strenuous, intense exercise done frequently is an environmental risk factor for amyotrophic lateral sclerosis in people with…
Stem Cells from Fat Tissue Protect Motor Neurons in ALS Mice
Stem cells derived from fat tissue significantly improved motor function and delayed disease onset by protecting motor neurons in a…
MDA Golf Events to Support Neuromuscular Research, Patient Care
Registration is now open for fundraising events at four championship golf courses, whose fees will be used to…